Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study Meeting Abstract

  

Authors:	Miller, K.; Scher, H. I.; Fizazi, K.; Basch, E. M.; Sternberg, C. N.; Hirmand, M.; Cella, D.; Ivanescu, C.; Phung, D.; Spalding, J. R.; Bui, C. N.; Holmstrom, S.; De Bono, J. S.
Abstract Title:	Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study
Meeting Title:	2013 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	6 Suppl.
Meeting Dates:	2013 Feb 14-16
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-02-20
Language:	English
ACCESSION:	WOS:000333679600020
DOI:	10.1200/jco.2013.31.6_suppl.17
PROVIDER:	wos
Notes:	Meeting Abstract: 17 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128851